SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-24-106465
Filing Date
2024-12-06
Accepted
2024-12-06 16:00:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea0223686-13da1patel_akari.htm SC 13D/A 49764
  Complete submission text file 0001213900-24-106465.txt   51291
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: SC 13D/A | Act: 34 | File No.: 005-87614 | Film No.: 241532180
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660
Business Address
Patel Samir Rashmikant (Filed by) CIK: 0001702447 (see all company filings)

Type: SC 13D/A